Ebola Vaccine Trials Could Start This Year

Vaccine developers are accelerating work on a candidate for the Bundibugyo strain of Ebola following cases in Congo and Uganda. Mark Feinberg, CEO of IAVI, said the candidate vaccine could enter human trials by year-end, according to Bloomberg.

Next story